Replies to post #48 on Immatics NV (IMTX)

[FACT-MASTER]

Just doing some review of 1Q/22 report here:

https://ih.advfn.com/stock-market/NASDAQ/immatics-nv-IMTX/stock-news/88273266/immatics-announces-first-quarter-2022-financial-re

Here is what caught my attention:

"The next data read-out for the IMA203 monotherapy cohort is planned for 2H 2022."

Hope the results are better than the IMA202 program which was terminated.

The dive on the chart sort of says results could be poor,however it has dropped on lighterish volume. We are well into 2H of 2022.